Abstract
Mechanical circulatory support represents an evolving field of clinical research and practice. Currently, several cardiac assist devices have been developed but, among different institutions and countries, a large variation in indications for use and device selection exists. The Impella platform is an easy to use percutaneous circulatory support device which is increasingly used worldwide. During 2014, we established a working group of European physicians who have collected considerable experience with the Impella device in recent years. By critically comparing the individual experiences and the operative protocols, this working group attempted to establish the best clinical practice with the technology. The present paper reviews the main theoretical principles of Impella and provides an up-to-date summary of the best practical aspects of device use which may help others gain the maximal advantage with Impella technology in a variety of clinical settings.
Lingua originale | English |
---|---|
pagine (da-a) | 684-691 |
Numero di pagine | 8 |
Rivista | International Journal of Cardiology |
Volume | 201 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Acute myocardial infarction
- Cardiogenic shock
- Expert group
- High-risk PCI
- Impella
- Mechanical support